About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Human Papillomavirus Education Programs | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT04880837

Human Papillomavirus Education Programs

This clinical trial aims to implement a culturally-tailored educational outreach actives with the goal of increasing knowledge of human papillomavirus (HPV) types that can lead to cancer and uptake of...

Lead sponsor: Ohio State University Comprehensive Cancer Center•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Ohio State University Comprehensive Cancer Center

PRIMARY OBJECTIVE: I. To implement culturally tailored educational outreach activities with the goal of increasing knowledge of HPV types that can lead to cancer and uptake of the available vaccine. OUTLINE: Participants attend educational session about HPV-related cancers, screening, and HPV vaccination and guidelines and receive informational infographic handout on HPV vaccination. Participants also complete surveys pre and post education session over 5 minutes each to assess HPV vaccination status among children of participants, HPV knowledge, and intentions to get the HPV vaccination, and screening among participants. Participants participate in surveys over telephone or face-to-face at 3 and 6 months.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•18 years of age and older
•From Ohio

Related studies

RECRUITINGPhase 1

Testing RG1-VLP Vaccine to Prevent HPV-related Cancers

NCT05985681 · Human Papillomavirus-Related Carcinoma

Not Yet RecruitingNA

Interpersonal Communication Training and Vaccination Workflow Training Alone and in Combination to Improve Communication and Recommendations About HPV Vaccination in Pharmacies, IMPACT HPV Trial

NCT06926062 · Human Papillomavirus-Related Carcinoma

COMPLETEDPhase 4

Immunogenicity and Safety of Human Papilloma Virus Vaccine in Solid Organ Transplant Recipients

NCT02624349 · Late Complication From Kidney Transplant, Complication of Transplanted Liver, and more

MeFirst: A Tailored Intervention to HPV Vaccine Decision Making

NCT01769560 · Human Papillomavirus-Related Carcinoma

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 2, 2023Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment12

Start dateApr 2022

Last updatedNov 2, 2023

Condition

Human Papillomavirus-Related Carcinoma

Locations shown

Ohio State University Comprehensive Cancer Center

Columbus, Ohio

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 2, 2023Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions